Literature DB >> 17958734

Esophageal adenocarcinoma developing above an Angelchik prosthesis.

S J Mercer1, S K C Toh, S S Somers.   

Abstract

The Angelchik device is a horseshoe-shaped prosthesis made of silicone elastomer; it was inserted by the trans-abdominal route to encircle the lower esophagus and was used in the treatment of gastro-esophageal reflux disease. Over 25 000 were inserted worldwide, with acceptable symptom control in between 54% and 95% of patients. However, they were associated with a wide variety of complications, including intractable dysphagia, prosthesis migration and erosion into the stomach, and a significant proportion had to be removed. This article details the cases of three patients in our institution who underwent the insertion of an Angelchik prosthesis and who subsequently developed adenocarcinoma of the esophagus. It is suggested that the Angelchik prosthesis does not effectively prevent acid reflux and thus has no effect in preventing the dysplasia-metaplasia-adenocarcinoma sequence in the lower esophagus.

Entities:  

Mesh:

Year:  2007        PMID: 17958734     DOI: 10.1111/j.1442-2050.2007.00698.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  3 in total

1.  Angelchik prosthesis with oesophageal adenocarcinoma: our surgical approach.

Authors:  V D Shetty; S G Thrumurthy; K G Pursnani; J B Ward; M M Mughal
Journal:  Ann R Coll Surg Engl       Date:  2010-07       Impact factor: 1.891

2.  Esophagogastric Fistula Caused by an Angelchik Antireflux Prosthesis.

Authors:  Mark M Pence; Mark Hubbard; Manish B Singla; Patrick E Young
Journal:  ACG Case Rep J       Date:  2015-07-09

3.  Systematic review of the introduction and evaluation of magnetic augmentation of the lower oesophageal sphincter for gastro-oesophageal reflux disease.

Authors:  E N Kirkham; B G Main; K J B Jones; J M Blazeby; N S Blencowe
Journal:  Br J Surg       Date:  2019-12-04       Impact factor: 6.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.